• Thu, April 4, 2024

Charles Duncan Reiterated (STOK) at Buy on, Apr 4th, 2024

Charles Duncan of Cantor Fitzgerald, Reiterated "Stoke Therapeutics, Inc." (STOK) at Buy on, Apr 4th, 2024.

Charles has made no other calls on STOK in the last 4 months.



There are 6 other peers that have a rating on STOK. Out of the 6 peers that are also analyzing STOK, 1 agrees with Charles's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jessica Fye of "JP Morgan" Maintained at Hold with Increased Target to $13 on, Tuesday, March 26th, 2024


These are the ratings of the 5 analyists that currently disagree with Charles


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Tuesday, March 26th, 2024
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $22 on, Tuesday, March 26th, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $17 on, Tuesday, March 26th, 2024
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $21 on, Tuesday, March 26th, 2024
  • Yaron Werber of "TD Cowen" Upgraded from Hold to Strong Buy on, Tuesday, March 26th, 2024